Leiden Bio Science Park recently welcomed a high-level delegation from the European Commission during a visit to Johnson & Johnson, organised by Amoy Anderson, and the team.
The visit centred on the impact of international trade on the Life Sciences and Health sectors, both in the Netherlands and the wider EU. The morning began with a welcome by Wietske Veltman, Alderman for Economy, Knowledge, Health, and Sports for the Municipality of Leiden, followed by a presentation from Esther Peters, Director of Leiden Bio Science Park.
Key speakers included Anneke Sanders (Bristol Myers Squibb), Jan de Sonneville (Life Science Methods), Anouk De Vroey (Johnson & Johnson), and Professor Thomas Hankemeier (Leiden University), who emphasised the Park’s strong academic and translational capabilities.
In the afternoon, Rob van Overbeek from Kadans Science Partner led a tour introducing the delegation to three innovative companies: LeydenJar (battery innovation), Meatable (sustainable food production), and VarmX (therapies for bleeding disorders).
The visit highlighted the Park’s role in fostering innovation and international collaboration, reinforcing its mission to support science that serves society.
Starting Friday, November 14 at 4:00 p.m., two temporary closures (in place for the duration of the Plesmanlaan project, until approximately Q3 2027) will be implemented for...
24 October 2025, Over the past 20 years, Dutch hospitals have filed 559 European patent applications. This emerges from a new study by the European Patent Office and Fraunhofer...
Leiden, 24 October 2025 at 3:03 PMResearchers at LUMC, together with colleagues from the University of Florida, have identified hundreds of proteins in the blood that provide...